饮食与肠道微生物群的相互作用和铁酸的生物可用性:对神经退行性疾病的影响
Saarika Pothuvan Kunnummal1,2, Mahejibin Khan3,4
1Department of Microbiology and Fermentation Technology, CSIR-Central Food Technological Research Institute, Mysore, Karnataka, 570020, India.
European journal of nutrition
|September 25, 2023
概括
铁酸 (FA) 的生物利用性是由产生铁酸化酶 (FAE) 的肠道微生物增强的. 通过饮食改变肠道微生物群可以帮助预防神经退行性疾病,如阿尔茨海默氏症和帕金森氏症.
科学领域:
- 微生物学 微生物学
- 神经科学是一个神经科学.
- 营养科学 营养科学
背景情况:
- 酸 (FA) 对于对抗氧化应激和神经退行至关重要,但其结合形式的吸收很差.
- 肠道微生物酸化酶 (FAE) 从食合物中释放出生物可利用的FA,影响全身健康.
- 饮食显著塑造肠道微生物群的组成和功能,影响宿主健康结果.
研究的目的:
- 探索一种以营养为基础的策略,通过调节产生FAE的肠道微生物群来预防神经退行性疾病.
- 突出肠道微生物群酶在从食物中释放有益化合物的作用.
主要方法:
- 关于铁酸,肠道微生物群和神经退行性疾病的科学文献的综述.
- 分析饮食,肠道酶 (FAE) 和宿主健康之间的相互作用.
- 讨论神经保护的营养药方法.
主要成果:
- 饮食成分影响肠道微生物群,产生像FAE这样的酶.
- FAE酶对于从食物中释放FA和其他抗氧化剂至关重要.
- 通过营养药物对FAE产生细菌的抑制可以增加FA的释放,并对抗神经退行.
结论:
- 通过饮食干预来改变肠道微生物群的多样性是预防神经退行性疾病的一个有希望的方法.
- 针对FAE产生肠道细菌提供了一种新的策略,可以提高FA的生物可用性和神经保护.
- 营养药疗法具有预防和辅助治疗神经退行性疾病的潜力.
相关概念视频
Alzheimer's Disease: Overview
513
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
513
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
348
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
348
Alzheimer's Disease: Treatment
212
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
212
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Physiology of Enteric Nervous System and Gut Health
294
The gastrointestinal tract, responsible for the digestion and absorption of nutrients, is safeguarded by the intestinal barrier, which consists of secretory, physical, and immune components. At the forefront is the secretory barrier, composed of essential elements such as mucus, gut microbiota, and defense proteins. They collaborate to break down food particles, facilitate nutrient absorption, and maintain optimal gut health. These secretory components ensure the smooth functioning of the...
294


